Pinkerton, Joann V <br/><br/>
Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.  [electronic resource] 

 -  Journal of women's health (2002)  Jan 2014 
 - 18-28 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1931-843X 
<br/><br/><label>Standard No.: </label>10.1089/jwh.2013.4392  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Estrogens--administration & dosage<br/>Estrogens, Conjugated (USP)--administration & dosage<br/>Female<br/>Health Status<br/>Hot Flashes--drug therapy<br/>Humans<br/>Indoles--administration & dosage<br/>Middle Aged<br/>Postmenopause--drug effects<br/>Quality of Life<br/>Selective Estrogen Receptor Modulators--administration & dosage<br/>Severity of Illness Index<br/>Surveys and Questionnaires<br/>Time Factors<br/>Treatment Outcome